Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award
- PMID: 32336227
- PMCID: PMC7225070
- DOI: 10.1161/HYPERTENSIONAHA.120.13896
Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award
Abstract
For over 100 years, essential hypertension has been researched from different perspectives ranging from genetics, physiology, and immunology to more recent ones encompassing microbiology (microbiota) as a previously underappreciated field of study contributing to the cause of hypertension. Each field of study in isolation has uniquely contributed to a variety of underlying mechanisms of blood pressure regulation. Even so, clinical management of essential hypertension has remained somewhat static. We, therefore, asked if there are any converging lines of evidence from these individual fields that could be amenable for a better clinical prognosis. Accordingly, here we present converging evidence which support the view that metabolic dysfunction underlies essential hypertension.
Keywords: blood pressure; cardiovascular disease; hypertension; hyperuricemia; mitochondria.
Figures


Similar articles
-
Editorial: Management of Elevated Heart Rate in Essential Hypertension: Pathophysiological Insights and Therapeutic Approach.Curr Pharm Des. 2017;23(31):4571-4572. doi: 10.2174/138161282331171204120822. Curr Pharm Des. 2017. PMID: 29260628 No abstract available.
-
Missing Heritability of Hypertension and Our Microbiome.Circulation. 2018 Oct 2;138(14):1381-1383. doi: 10.1161/CIRCULATIONAHA.118.036224. Circulation. 2018. PMID: 30354349 No abstract available.
-
Sex differences in hypertension: lessons from spontaneously hypertensive rats (SHR).Clin Sci (Lond). 2021 Aug 13;135(15):1791-1804. doi: 10.1042/CS20201017. Clin Sci (Lond). 2021. PMID: 34338771 Free PMC article. Review.
-
Mitochondrial Isolevuglandins Contribute to Vascular Oxidative Stress and Mitochondria-Targeted Scavenger of Isolevuglandins Reduces Mitochondrial Dysfunction and Hypertension.Hypertension. 2020 Dec;76(6):1980-1991. doi: 10.1161/HYPERTENSIONAHA.120.15236. Epub 2020 Oct 5. Hypertension. 2020. PMID: 33012204 Free PMC article.
-
Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension.Hypertension. 2019 Dec;74(6):1279-1293. doi: 10.1161/HYPERTENSIONAHA.119.13079. Epub 2019 Nov 4. Hypertension. 2019. PMID: 31679421 Review.
Cited by
-
Comparison of the Chemical Components, Efficacy and Mechanisms of Action of Chrysanthemum morifolium Flower and Its Wild Relative Chrysanthemum indicum Flower against Liver-Fire Hyperactivity Syndrome of Hypertension via Integrative Analyses.Int J Mol Sci. 2022 Nov 9;23(22):13767. doi: 10.3390/ijms232213767. Int J Mol Sci. 2022. PMID: 36430265 Free PMC article.
-
The Role of Unobtrusive Home-Based Continuous Sensing in the Management of Postacute Sequelae of SARS CoV-2.J Med Internet Res. 2022 Jan 26;24(1):e32713. doi: 10.2196/32713. J Med Internet Res. 2022. PMID: 34932496 Free PMC article.
-
The damaging duo: Obesity and excess dietary salt contribute to hypertension and cardiovascular disease.Obes Rev. 2023 Aug;24(8):e13589. doi: 10.1111/obr.13589. Epub 2023 Jun 19. Obes Rev. 2023. PMID: 37336641 Free PMC article. Review.
-
Identifying a metabolomics profile associated with masked hypertension in two independent cohorts: Data from the African-PREDICT and SABPA studies.Hypertens Res. 2022 Nov;45(11):1781-1793. doi: 10.1038/s41440-022-01010-2. Epub 2022 Sep 2. Hypertens Res. 2022. PMID: 36056205
-
Six Decades of History of Hypertension Research at the University of Toledo: Highlighting Pioneering Contributions in Biochemistry, Genetics, and Host-Microbiota Interactions.Curr Hypertens Rep. 2022 Dec;24(12):669-685. doi: 10.1007/s11906-022-01226-0. Epub 2022 Oct 27. Curr Hypertens Rep. 2022. PMID: 36301488 Free PMC article. Review.
References
-
- Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the united states during the 20th century. JAMA. 1999;281:61–66. - PubMed
-
- Centers for Disease C, Prevention. Control of infectious diseases. MMWR Morb Mortal Wkly Rep. 1999;48:621–629. - PubMed
-
- Chatterjee A, Modarai M, Naylor NR, Boyd SE, Atun R, Barlow J, Holmes AH, Johnson A, Robotham JV. Quantifying drivers of antibiotic resistance in humans: A systematic review. Lancet Infect Dis. 2018;18:e368–e378. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources